256 related articles for article (PubMed ID: 11958362)
1. Use of olanzapine for elderly patients with psychotic disorders: a review.
Madhusoodanan S; Sinha S; Brenner R; Gupta S; Bogunovic O
Ann Clin Psychiatry; 2001 Dec; 13(4):201-13. PubMed ID: 11958362
[TBL] [Abstract][Full Text] [Related]
2. Review of recent clinical studies with olanzapine.
Tollefson GD; Kuntz AJ
Br J Psychiatry Suppl; 1999; (37):30-5. PubMed ID: 10211139
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study.
Madhusoodanan S; Brenner R; Suresh P; Concepcion NM; Florita CD; Menon G; Kaur A; Nunez G; Reddy H
Ann Clin Psychiatry; 2000 Mar; 12(1):11-8. PubMed ID: 10798821
[TBL] [Abstract][Full Text] [Related]
4. Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders.
Lambert M; Holzbach R; Moritz S; Postel N; Krausz M; Naber D
Int Clin Psychopharmacol; 2003 Sep; 18(5):251-60. PubMed ID: 12920385
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine: a novel atypical neuroleptic agent.
Reus VI
Lancet; 1997 May; 349(9061):1264-5. PubMed ID: 9142055
[No Abstract] [Full Text] [Related]
6. Olanzapine: an atypical antipsychotic for schizophrenia.
Lund BC; Perry PJ
Expert Opin Pharmacother; 2000 Jan; 1(2):305-23. PubMed ID: 11249551
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of olanzapine for the treatment of geriatric psychosis.
Hwang JP; Yang CH; Lee TW; Tsai SJ
J Clin Psychopharmacol; 2003 Apr; 23(2):113-8. PubMed ID: 12640211
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine: an updated review of its use in the management of schizophrenia.
Bhana N; Foster RH; Olney R; Plosker GL
Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
[TBL] [Abstract][Full Text] [Related]
9. Adverse events related to olanzapine.
Conley RR; Meltzer HY
J Clin Psychiatry; 2000; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240
[TBL] [Abstract][Full Text] [Related]
10. Schizophrenia and schizoaffective disorder treated with high doses of olanzapine.
Fanous A; Lindenmayer JP
J Clin Psychopharmacol; 1999 Jun; 19(3):275-6. PubMed ID: 10350037
[No Abstract] [Full Text] [Related]
11. Switching treatment-resistant patients with schizophrenia or schizoaffective disorder to olanzapine: a one-year open-label study with five-year follow-up.
Karagianis JL; LeDrew KK; Walker DJ
Curr Med Res Opin; 2003; 19(6):473-80. PubMed ID: 14594518
[TBL] [Abstract][Full Text] [Related]
12. Comments on "Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders" by Tran and Associates.
Kasper S; Küfferle B
J Clin Psychopharmacol; 1998 Aug; 18(4):353-6. PubMed ID: 9690709
[No Abstract] [Full Text] [Related]
13. Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses.
Fulton B; Goa KL
Drugs; 1997 Feb; 53(2):281-98. PubMed ID: 9028746
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine.
Weiss EL; Longhurst JG; Bowers MB; Mazure CM
J Clin Psychopharmacol; 1999 Aug; 19(4):378-80. PubMed ID: 10440469
[No Abstract] [Full Text] [Related]
15. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
16. Quality of life and atypical antipsychotics.
Rudnick A
J Clin Psychopharmacol; 1998 Oct; 18(5):424-5. PubMed ID: 9790165
[No Abstract] [Full Text] [Related]
17. Olanzapine: a new antipsychotic agent with efficacy in the management of schizophrenia.
Kando JC; Shepski JC; Satterlee W; Patel JK; Reams SG; Green AI
Ann Pharmacother; 1997 Nov; 31(11):1325-34. PubMed ID: 9391688
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.
Tran PV; Hamilton SH; Kuntz AJ; Potvin JH; Andersen SW; Beasley C; Tollefson GD
J Clin Psychopharmacol; 1997 Oct; 17(5):407-18. PubMed ID: 9315992
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine.
Hale AS
Br J Hosp Med; 1997 Nov 5-18; 58(9):442-5. PubMed ID: 9619205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
